Incyte

Incyte

INCY· Services· Fiscal year ends in December

CEO pay in FY2025Stock +43.0% in FY2025

William J. Meury is the CEO of Incyte and was paid $32.1M in FY2025 (Dec).

Pay$100 in the stock at the end of FY20 → $162
CEO pay is from each Incyte proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives7

See all
  1. 1William J. MeuryFY2025
  2. 2Mohamed IssaFY2025
  3. 3Pablo J. CagnoniFY2025
  4. 4Hervé HoppenotFY2025
  5. 5Steven H. SteinFY2025
  6. 6Christiana StamoulisFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Incyte paid its 7 named executives $70.1M in total in FY2025 (Dec). CEO Hervé Hoppenot was paid $6.4M of that.

Name
William J. MeuryChief Executive OfficerNot disclosedNot disclosed
Mohamed IssaExecutive Vice President and Head of U.S. CommercialNot disclosedNot disclosed
Pablo J. CagnoniPresident, Research and Development
Hervé HoppenotPresident and Chief Executive Officer
Steven H. SteinExecutive Vice President and Chief Medical Officer
Christiana StamoulisExecutive Vice President and Chief Financial Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Incyte. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board4

See all
  • Julian C. BakerChair · 24 yr on the boardIndependentCompensation, Nominating and Corporate Governance (Chair)—Paid as an executive
  • Jacqualyn A. Fouse, Ph.D.Director · 8 yr on the boardIndependentAudit and Finance, Nominating and Corporate Governance—Paid as an executive
  • Katherine A. High, M.D.Director · 5 yr on the boardIndependentScience and Technology—Paid as an executive
  • Otis W. Brawley, M.D.Director · 4 yr on the boardIndependentScience and Technology—Paid as an executive

The board of the latest proxy (FY2025).

Shared directors

Activity

Filings24

See all
Current report8-KJun 9, 2026—
Proxy statementDEF 14AApr 28, 2026FY2025
Current report8-KMar 30, 2026—
Current report8-KMar 26, 2026—
Annual report10-KFeb 10, 2026FY2025
Current report8-KDec 12, 2025—